Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely
used in the ongoing COVID-19 pandemic. In this paper, we review the properties of mAbs …

The mutation rate of the Omicron sublineage has led to baseline resistance against all
previously authorized anti-Spike monoclonal antibodies (mAbs). Nevertheless, in case more …

An early warning system for emerging SARS-CoV-2 variants | Nature Medicine Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

The availability of three COVID-19 vaccines in the United States provides an unprecedented
opportunity to examine how vaccine platforms and timing of vaccination in pregnancy impact …

The effect of SARS-CoV-2 infection on placental function is not well understood. Analysis of
placentas from women who tested positive at delivery showed SARS-CoV-2 genomic and …

Real-world data on vaccine-elicited neutralising antibody responses for two-dose AZD1222
in African populations are limited. We assessed baseline SARS-CoV-2 seroprevalence and …

The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and
caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed …

As concerns related to the COVID-19 pandemic continue, it is critical to understand the
impact of vaccination type on neutralizing antibody response durability as well as to identify …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produced diverse
molecular variants during its recent expansion in humans that caused different …

SARS-CoV-2 vaccines have shown very high effectiveness in real-world scenarios.
However, there is compelling evidence for a fast-paced waning of immunity. The increasing …